This activity has expired. CME/CE credit is no longer available and the following content may not be up-to-date.
Start the program by clicking on the Start Program icon at the bottom of this page.
Program Title
Update from Europe: Discussing Lessons from the 2009 EORTC-EANO Meeting
Release Date: May-04-09
Credit Expiration Date: May-31-10
Program Developer/Facilitator
Medical Communications Media, Inc.
Target Audience
This program, developed by experts in neuro-oncology, radiation oncology, and neurosurgery, has been designed for physicians who interact with oncology patients.
Credit Hours
CME 0.5
Medium
Podcast (MP3 & PDF)
Program Description
CREDIT FOR THIS PROGRAM IS AVAILABLE FOR PHYSICIANS ONLY.
Since the 1970s the Brain Tumor Group of the European Organisation for Research and Treatment of Cancer (EORTC) has pioneered groundbreaking protocols in the management of brain malignancies. Formed in the early 1990s, the European Association of Neuro-Oncology (EANO) was created specifically to further knowledge in the speciality of neuro-oncology. In March 2009, these two groups held the first in a series of joint conferences to be held biennially. Titled
“Trends in Central Nervous System Malignancies,”
the first EORTC-EANO meeting was held in Budapest, co-chaired by EORTC Brain Tumor Group chairman Martin van den Bent, MD.* In this brief CME-accredited audio interview, radiation oncologist Minesh Mehta, MD, reviews the highlights of this historic conference with van den Bent and fellow EORTC-EANO participants neuro-oncologist Roger Stupp, MD, and neurosurgeon Frederick Lang, MD. This fascinating interchange with world-renowned leaders in neuro-oncology touches upon such vanguard subjects as cognitive rehabilitation, markers for prognosis and diagnosis, personalized treatment, and emerging therapies.
*For more information go to http://groups.eortc.be/brain
Learning Objectives
Upon completion of this educational activity, the participant should be able to:
1.
Evaluate the latest concepts in the diagnosis and prognosis of brain tumors.
2.
Discuss the possible future directions in personalized therapy.
Faculty
Moderator/Interviewer
Minesh P. Mehta, MD
Professor of Human Oncology
University of Wisconsin-Madison
Madison, Wisconsin
Frederick F. Lang, MD
Professor of Neurosurgery
The University of Texas MD Anderson Cancer Center
Houston, Texas
Roger Stupp, MD
Head, Neuro-Oncology
Department of Neurosurgery
University Hospital CHUV
Lausanne, Switzerland
Chief, Oncology-Hematology
Riviera & Chablais Hospitals
Vevey, Switzerland
Martin J. van den Bent, MD, PhD
Professor in Neuro-Oncology
Head, Neuro-Oncology Unit
Daniel den Hoed Cancer Center
Erasmus University Medical Center
Rotterdam, The Netherlands
Disclosures
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The faculty must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflict of interest is resolved by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.
Dr. Mehta
discloses product consultation for Genentech and Tomotherapy and speakers’ bureau participation for Schering-Plough. He also owns stock in Pharmacyclics and Tomotherapy.
Dr. Stupp
discloses product consultation for Merck-KGaA in Darmstadt, Germany, Roche AG in Basel, Switzerland, and Novocure in the UK. He is also a speakers’ bureau participant for Merck-KGaA, and owns stock in Pfizer.
Drs. Lang and van den Bent
indicate they have no actual or potential conflict of interest to this program.
This educational activity may contain discussion of investigational uses of pharmaceutical agents or surgical devices. Some of these agents/devices may not have been approved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Commercial Support Statements
Supported through an educational grant from Schering-Plough.
Credit Statements
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of AKH Inc. and Medical Communications Media. AKH Inc. is accredited by the ACCME to provide continuing medical education for physicians.
AKH Inc. designates this educational activity for a maximum of 0.5
AMA PRA Category 1 Credit
™
. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Instructions
This program consists of a Podcast/MP3 audio file and a printable PDF of the post-test that can be submitted for credit and/or used to assist learning. You may play the audio online or download the file to an MP3 audio player, such as an iPod. You will also need Adobe Acrobat Reader to view and print the PDF post-test and evaluation.
1.
Click on the "Start program" icon. This will bring you to the login/registration page where you will be able to register as a new GliomaEd.com member or check/revise existing registration information.
2.
Update your existing registration information, if necessary. When ready, click on the "Continue to Program" icon at the top or bottom of the screen. This will take you to the podcast description page.
3.
Save the PDF file to your computer or open the file using the Adobe Acrobat Reader. Print a copy of the PDF, which includes the post-test and program evaluation. This can be used as a learning aid while you listen to the audio file.
4.
Download or play the audio file by clicking on the appropriate button. Instructions for utilizing this program on a portable MP3 player such as an iPod can be found on this page.
5.
Listen to the presentation before filling out the post-test and evaluation. It should take approximately 30 minutes to listen to the audio and complete the post-test and evaluation.
6.
There are two ways to receive CME credit: online or via postal service. To complete online, follow the link to the post-test. Successful completion of the post-test and evaluation online will enable you to immediately print a statement of credit. Credit is awarded for a score of 80% or better on the post-test and completion of the evaluation. Alternately, complete the post-test and evaluation found on the last two pages of the PDF. Mail the pages according to the printed instructions. A certificate will be mailed within 6 weeks.
Certificate Fee
$0.00
Disclaimer
©2009 Medical Communications Media, Inc. All rights reserved. This publication is designed for use with this audio recording. None of the contents may be reproduced in any form without prior written permission from the publisher. The opinions expressed in the audio recording are those of the presenters and do not necessarily reflect the opinions or recommendations of their affiliated institutions, the publisher, AKH Inc., or Schering-Plough. Any medications, diagnostic procedures, or treatments discussed by the program presenters should not be used by clinicians or other healthcare professionals without first evaluating their patients’ conditions, considering possible contraindications or risks, reviewing any applicable manufacturer’s product information, and comparing any therapeutic approach with the recommendations of other authorities.
By clicking START PROGRAM I acknowledge that I have read the CME/CE information above.
Related Programs
Title
Audience
Medium
